Resolution of in flammation: state of the art, definitions and terms
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
A recent focus meeting on Controlling Acute Inflammation was held in London, April 27–28, 2006, organized by D.W. Gilroy and S.D. Brain for the British Pharmacology Society. We concluded at the meeting that a consensus report was needed that addresses the rapid progress in this emerging field and details how the specific study of resolution of acute inflammation provides leads for novel anti‐inflammatory therapeutics, as well as defines the terms and key components of interest in the resolution process within tissues as appreciated today. The inflammatory response protects the body against infection and injury but can itself become dysregulated with deleterious consequences to the host. It is now evident that endogenous biochemical pathways activated during defense reactions can counter‐regulate inflammation and promote resolution. Hence, resolution is an active rather than a passive process, as once believed, which now promises novel approaches for the treatment of inflammation‐associated diseases based on endogenous agonists of resolution.—Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., Wallace, J. L. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21, 325–332 (2007)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The process of inflammation resolution involves not only passive mechanisms, e.g., dissipation of chemotactic gradient or initial danger signals, but also active biochemical pathways [103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326 · cited 3×
“TLRs and NLRs also sense products of inflamed tissue, and notable examples are the sensing of low MW hyaluronic acid fragments by TLR2 and TLR4 (13) and the sensing of uric acid by Nalp3 (14).”
Background(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,529
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552 · cited 2×
“1C), may lead to prolonged inflammation and the inability for the tissue to return to homeostasis (26) and complete the full life-cycle per se of the neutrophils and mononuclear cells recruited to the tissue.”
BackgroundSelf-citationAgostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768 · cited 1×
“Nalp3 occurs in an inflammasome complex with caspase-1, ASC, cardinal, and Nalp2 ( 12 ).”
BackgroundMolecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684 · cited 1×
“Uric acid is the causative agent of gout but is also released by damaged cells, possibly as a general signal for inflammation (15).”
BackgroundSerhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650 · cited 1×
“Additionally, the widely used aspirin jump-starts resolution by making up for its loss in prostaglandin production, which plays key roles in resolution, by instead generating the epimeric version of lipid mediators (25), such as the aspirin-triggered lipoxins (recently reviewed in ref.”
BackgroundSelf-citationNegative regulation of Toll-like receptor-mediated immune responses
Liew, F. Y., Xu, D., Brint, E. K., & O'Neill, L. A. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1630 · Cited by 1,509 · cited 8×
“In effect, TLRs sow the seeds of their own destruction, and the role of negative regulators clearly indicates how robust the TLR system is.”
BackgroundInfluentialSelf-citationLipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453 · cited 1×
“enzymes are expressed (31), and whether it is resolving”
BackgroundSelf-citationRegulation of lung injury and repair by Toll-like receptors and hyaluronan
Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G. D., Mascarenhas, M. M., Garg, H. G., Quinn, D. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1315 · Cited by 1,401 · cited 4×
“TLRs and NLRs also sense products of inflamed tissue, and notable examples are the sensing of low MW hyaluronic acid fragments by TLR2 and TLR4 (13) and the sensing of uric acid by Nalp3 (14).”
BackgroundInfluentialInducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Self-citation
Cited by
Items 401–500 of 1,000
Ni, K.-D., & Liu, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.716801 · Cited by 57
Serhan, C. N., & Chiang, N. (2023) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2023.106718 · Cited by 59
Self-citationBiomarkers of vasospasm development and outcome in aneurysmal subarachnoid hemorrhage
Rodríguez-Rodríguez, A., Egea-Guerrero, J. J., de Azúa-López, Z. R., & Murillo-Cabezas, F. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.04.020 · Cited by 54
“As a result of bleeding in SAH, a primary immune response is immediately triggered, mediated by macrophages and neutrophils [14, 15], which enter the subarachnoid space due to the expression of specific cell adhesionmolecules (CAMs) on the luminal surface of endothelial cells, expression upregulated by RBC lysis [16].”
Dual role of lipoxin A4 in pneumosepsis pathogenesis
Sordi, R., Menezes‐de‐Lima, O., Horewicz, V. V., Scheschowitsch, K., Santos, L. F. D., & Assreuy, J. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.06.010 · Cited by 51
“However, the timing of production/effect of LXA4 is crucial for this beneficial pro-resolution and anti-inflammatory role [22].”
BackgroundLee, C.-T., & Repasky, E. A. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00140 · Cited by 57
Rostoker, R., Yaseen, H., Schif‐Zuck, S., Lichtenstein, R. G., Rabinovich, G. A., & Ariel, A. (2013) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2013.08.001 · Cited by 58
“[1] Serhan CN, Brain SD, Buckley CD, et al.”
BackgroundYurdagul, A., Kong, N., Gerlach, B. D., Wang, X., Ampomah, P. B., Kuriakose, G., Tao, W., Shi, J., & Tabas, I. A. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315622 · Cited by 56
Jin, H., Liu, K., Tang, J., Huang, X., Wang, H., Zhang, Q., Zhu, H., Li, Y., Pu, W., Zhao, H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23197-7 · Cited by 50
Resolution-Based Therapies: The Potential of Lipoxins to Treat Human Diseases
Jaén, R. I., Sánchez‐García, S., Fernández‐Velasco, M., Boscá, L., & Prieto, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658840 · Cited by 55
“Lipoxins 5-, 12- and 15-lipoxygenases Arachidonic Acid (AA) (1)”
BackgroundOxidation of Polyunsaturated Fatty Acids as a Promising Area of Research in Infertility
Collodel, G., Moretti, E., Noto, D., Corsaro, R., & Signorini, C. (2022) · Antioxidants · doi:10.3390/antiox11051002 · Cited by 59
“Tissue remodelling is a typical event in the resolution of inflammation that aims to repair lesions caused by etiological agents and to which the activity of inflammatory cells contributes [95].”
BackgroundAllegra, M., D’Acquisto, F., Tesoriere, L., Attanzio, A., & Livrea, M. A. (2014) · Redox Biology · doi:10.1016/j.redox.2014.07.004 · Cited by 51
“…Charterhouse Square, London EC1M 6BQ, United Kingdom a r t i c l e i n f o Article history: Received 27 June 2014 Received in revised form 9 July 2014 Accepted 11 July 2014 Available online 21 July 2014 Keywords: Indicaxanthin Phytochemicals Eicosanoids Inflammation Oxidative…”
BackgroundInfluentialResolution, the grail for healthy ocular inflammation
Gronert, K. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.07.004 · Cited by 55
“…differentiation and directly stimulate macrophages to phagocytose apoptotic PMN; a new paradigm that has been the subjective of recent reviews (Lawrence et al., 2002; Gilroy et al., 2004; Serhan and Savill, 2005; Serhan et al., 2007; Gronert, 2008; Kennedy and DeLeo, 2009; Nathan and Ding, 2010).”
BackgroundInfluentialAizawa, M., Gotohda, N., Takahashi, S., Konishi, M., & Kinoshitá, T. (2011) · World Journal of Surgery · doi:10.1007/s00268-011-1269-2 · Cited by 50
“Neutrophils represent early acute inflammation and migrate to the affected sites to neutralize and eliminate potentially injurious stimuli [24].”
BackgroundFrasch, S. C., Fernandez-Boyanapalli, R. F., Berry, K. A. Z., Murphy, R. C., Leslie, C. C., Nick, J. A., Henson, P. M., & Bratton, D. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.438507 · Cited by 55
“Indeed, the critical accumulation of neutrophils in tissues at any point in time is the net sum of both the processes of recruitment and removal (3).”
BackgroundWolfer, A. M., Gaudin, M., Taylor-Robinson, S. D., Holmes, E. C., & Nicholson, J. K. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b02794 · Cited by 55
Maresin 1 induces a novel pro‐resolving phenotype in human platelets
Lannan, K. L., Spinelli, S., Blumberg, N., & Phipps, R. P. (2017) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13620 · Cited by 55
Pro-resolving lipid mediators: Agents of anti-ageing?
Doyle, R., Sadlier, D. M., & Godson, C. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.002 · Cited by 54
Toita, R., Shimizu, E., Murata, M., & Kang, J. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.12.052 · Cited by 53
Inflammation Regulates the Multi-Step Process of Retinal Regeneration in Zebrafish
Nagashima, M., & Hitchcock, P. F. (2021) · Cells · doi:10.3390/cells10040783 · Cited by 51
“In contrast to acute inflammation, dysregulation of inflammation in response to cell death can result in chronic inflammation, which is both detrimental to the injured tissue and incompatible with regeneration [7].”
BackgroundMontero‐Melendez, T., Gobbetti, T., Cooray, S. N., Jonassen, T. E. N., & Perretti, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402645 · Cited by 51
“Such an approach, we propose, would yield therapeutics that would not be resolution toxic by repressing or delaying tissue repair processes and the ensuing restoration of homeostasis (40).”
BackgroundSelf-citationHaynes, R. L., & van Leyen, K. (2013) · Developmental Neuroscience · doi:10.1159/000350230 · Cited by 55
Zhang, Y., McClain, S. A., Lee, H., Elburki, M. S., Yu, H., Gu, Y., Zhang, Y., Wolff, M. S., Johnson, F., & Golub, L. M. (2016) · Journal of Diabetes Research · doi:10.1155/2016/5782904 · Cited by 50
Tajbakhsh, A., Gheibi Hayat, S. M., Butler, A. E., & Sahebkar, A. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.01.007 · Cited by 49
Lim, C. S., Porter, D. W., Orandle, M. S., Green, B. J., Barnes, M. A., Croston, T. L., Wolfarth, M. G., Battelli, L. A., Andrew, M. E., Beezhold, D. H., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01186 · Cited by 55
Giovannoni, M. P., Schepetkin, I. A., Cilibrizzi, A., Crocetti, L., Khlebnikov, А. I., Dahlgren, C., Graziano, A., Piaz, V. D., Kirpotina, L. N., Zerbinati, S., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.03.066 · Cited by 48
Zurier, R. B., Sun, Y., George, K. L., Stebulis, J. A., Rossetti, R. G., Skulas‐Ray, A. C., Judge, E., & Serhan, C. N. (2009) · The FASEB Journal · doi:10.1096/fj.08-118323 · Cited by 50
“Both PGD2 and PGJ2, like LXA4, facilitate resolution of inflammation (27, 28).”
BackgroundSelf-citationNeutrophils and inflammatory resolution in the mucosa
Colgan, S. P. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.007 · Cited by 51
Machado, F. S., Esper, L., Dias, A., Madan, R., Gu, Y., Hildeman, D. A., Serhan, C. N., Karp, C. L., & Aliberti, J. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072416 · Cited by 47
Self-citationRetractedModulation of granulocyte apoptosis can influence the resolution of inflammation
Rossi, A. G., Hallett, J. M., Sawatzky, D. A., Teixeira, M. M., & Haslett, C. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350288 · Cited by 59
Self-citationAronoff, D. M., Lewis, C. A., Serezani, C. H., Eaton, K. A., Goel, D., Phipps, J. C., Peters-Golden, M. L., & Mancuso, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900129 · Cited by 47
“The latter actions counterregulate host inflammatory responses, potentially limiting collateral damage to neighboring cells and tissues and aiding in the resolution of inflammation once pathogens are contained (14).”
BackgroundRecchiuti, A., Codagnone, M., Pierdomenico, A. M., Rossi, C., Mari, V. C., Cianci, E., Simiele, F., Gatta, V., & Romano, M. (2014) · The FASEB Journal · doi:10.1096/fj.13-248393 · Cited by 53
“They also support the therapeutic applicability of RvD1 as a dual-acting drug that simultaneously dampens excessive PMN influx and stimulates resolution activities of M s, which is a relevant clinical issue, since a number of anti-inflammatory molecules are toxic to resolution (3, 11).”
BackgroundSlow resolution of inflammation in severe adult dengue patients
Zhao, L., Huang, X., Hong, W., Qiu, S., Wang, J., Yu, L., Zeng, Y., Tan, X., & Zhang, F. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1596-x · Cited by 48
“providing protection against infection and normally terminated once the infection is cleared, while it is detrimental when dysregulated [10, 11].”
BackgroundStama, M. L., Ślusarczyk, J., Lacivita, E., Kirpotina, L. N., Schepetkin, I. A., Chamera, K., Riganti, C., Perrone, R., Quinn, M. T., Basta‐Kaim, A., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.09.023 · Cited by 57
“This latter aspect has gained interest in recent years because several classes of peptidic or non-peptidic endogenous factors have been identified as pro-resolving mediators [7].”
BackgroundIrún, P., Lanas, Á., & Piazuelo, E. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00852 · Cited by 51
“…activation of 15-lipoxygenase (15-LOX) in neutrophils and then producing the first class of endogenous specialized pro-resolving lipid mediator (SPM), AA-derived, called lipoxins (LXs), stop-and-go signals for inflammation and resolution phases (Qiu et al., 2001; Nathan, 2002; Serhan, 2007).”
BackgroundInflammatory macrophages, and not only neutrophils, die by apoptosis during acute peritonitis
Kołaczkowska, E., Kozioł, A., Płytycz, B., & Arnold, B. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.07.001 · Cited by 47
Pepe, R. B., Lottenberg, A. M., Fujiwara, C. T. H., Beyruti, M., Cintra, D. E., Machado, R. M., Rodrigues, A., Jensen, N. S. O., Caldas, A. P. S., Fernandes, A. E., et al. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01037-6 · Cited by 71
Long, H., Lichtnekert, J., Andrassy, J., Schraml, B. U., Romagnani, P., & Anders, H.-J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1194988 · Cited by 46
The effect of galectins on leukocyte trafficking in inflammation: sweet or sour?
Cooper, D., Iqbal, A. J., Gittens, B. R., Cervone, C., & Perretti, M. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06291.x · Cited by 49
Self-citationRtibi, K., Jabri, M., Selmi, S., Souli, A., Sebaï, H., Benna, J. E., Amri, M., & Marzouki, L. (2015) · RSC Advances · doi:10.1039/c5ra14719k · Cited by 52
Tani, Y., Isobe, Y., Imoto, Y., Segi‐Nishida, E., Sugimoto, Y., Arai, H., & Arita, M. (2014) · The FASEB Journal · doi:10.1096/fj.14-251132 · Cited by 48
“Several studies have shown that distinct subsets of macrophages are involved in the regulation of inflammatory responses (2, 3, 9, 15, 16), and the finding that eosinophils regulate the phenotype of adipose tissue macrophages (17) prompted us to examine whether eosinophils modulate macrophage phenotypes during the res…”
BackgroundOmega-3-derived mediators counteract obesity-induced adipose tissue inflammation
Titos, E., & Clària, J. (2013) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2013.05.003 · Cited by 57
“003 highly orchestrated program coordinated by a complex regulatory network of cells and mediators that switch inflammation off in a specific time-limited manner [3].”
BackgroundInfluentialResolution of inflammation and mood disorders
Chistyakov, D. V., Astakhova, A. A., & Sergeeva, M. G. (2018) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2018.08.002 · Cited by 74
Night work effects on salivary cytokines TNF, IL-1β and IL-6
Reinhardt, É. L., Fernandes, P. A. C. M., Markus, R. P., & Fischer, F. M. (2018) · Chronobiology International · doi:10.1080/07420528.2018.1515771 · Cited by 59
“As with the onset phase of acute inflammation, each step of the resolution of inflammation is also highly coordinated and under tight control (Serhan et al. 2007).”
Backgroundvan der Does, A. M., Heijink, M., Mayboroda, O. A., Persson, L. J. P., Aanerud, M., Bakke, P. S., Eagan, T., Hiemstra, P. S., & Giera, M. A. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.11.012 · Cited by 46
What Formyl Peptide Receptors, if Any, Are Triggered by Compound 43 and Lipoxin A4?
Forsman, H. F., Önnheim, K., Andréasson, E., & Dahlgren, C. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02570.x · Cited by 46
Leoni, G., Patel, H., Sampaio, A. L. F., Gavins, F. N. E., Murray, J. F., Grieco, P., Getting, S. J., & Perretti, M. (2008) · The FASEB Journal · doi:10.1096/fj.08-113886 · Cited by 51
Self-citationMacrophage Efferocytosis in Cardiac Pathophysiology and Repair
Li, Y., Li, Q., & Fan, G. (2020) · Shock · doi:10.1097/shk.0000000000001625 · Cited by 48
“Unauthoriz undergoing apoptosis shortly after reaching the infarcted myocardium and disintegrate after 48 h (111, 112).”
BackgroundBhutta, M. F. (2015) · Human Biology · doi:10.13110/humanbiology.87.2.0092 · Cited by 50
Temme, S., Jacoby, C., Ding, Z., Bönner, F., Borg, N., Schrader, J., & Flögel, U. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0113032 · Cited by 49
“However, the matrigel/LPS model displays an extended time frame of neutrophil immigration and a prolonged resolution phase compared with other well-established models of inflammation, such as murine models of zymosan-induced peritonitis or TNF- -elicited inflammation in a murine air-pouch [9, 10, 24].”
BackgroundPierdomenico, A. M., Recchiuti, A., Simiele, F., Codagnone, M., Mari, V. C., Davì, G., & Romano, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.592352 · Cited by 47
5-Lipoxygenase–Deficient Mice Infected with Borrelia burgdorferi Develop Persistent Arthritis
Blaho, V. A., Zhang, Y., Hughes-Hanks, J. M., & Brown, C. R. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003473 · Cited by 45
17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice
Yatomi, M., Hisada, T., Ishizuka, T., Koga, Y., Ono, A., Kamide, Y., Seki, K., Aoki‐Saito, H., Tsurumaki, H., Sunaga, N., et al. (2015) · Physiological Reports · doi:10.14814/phy2.12628 · Cited by 50
“Inflammation is a fundamental component of host defense, which specifically evolved to protect and restore tissue homeostasis by removing deleterious agents and associated damaged tissue (Serhan et al. 2007; Sun et al. 2007).”
BackgroundLam, D., Harris, D., & Qin, Z. (2013) · Mediators of Inflammation · doi:10.1155/2013/931562 · Cited by 52
“The resolution stage of inflammation is defined as the interval from maximum neutrophilic accumulation to the point at which neutrophils are fully removed from the tissue [24].”
BackgroundStroma: Fertile soil for inflammation
Patel, R., Filer, A. D., Barone, F., & Buckley, C. D. (2014) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2014.10.022 · Cited by 50
“For an inflammatory response to resolve completely, these gradients must be removed, and leucocytes must be cleared from the site of pathology, either by migration out of the site, or via apoptosis (1).”
BackgroundSelf-citationPerucci, L. O., Sugimoto, M. A., Gomes, K. B., Dusse, L. M. S., Teixeira, M. M., & Sousa, L. P. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1364363 · Cited by 49
“lead to further tissue damage and loss of organ function [2,3].”
BackgroundLiang, C., Pang, J., Lee, Y. H., Ooi, E. E., Ong, C. N., Leo, Y., & Tannenbaum, S. R. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006217 · Cited by 50
Neuroinflammation in Alzheimer's disease and beneficial action of luteolin
Delgado, A., Cholevas, C., & Theoharides, T. C. (2021) · BioFactors · doi:10.1002/biof.1714 · Cited by 48
“In healthy individuals, the normal microglial response concludes upon clearance of the original stimuli, entering a resolved state that includes downregulation of inflammation through specialized proresolving mediators (SMPs).(52,53) SMPs are decreased levels in the brain tissue and CSF of AD patients.”
BackgroundLeoni, G., Voisin, M., Carlson, K. E., Getting, S. J., Nourshargh, S., & Perretti, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00688.x · Cited by 48
“In line with the potential exploitation of other endogenous anti-inflammatory pathways and targets for the development of novel anti-inflammatory drugs (Gilroy et al., 2004; Gonzalez-Rey et al., 2007; Serhan et al., 2007), it is possible that activation of MC receptors would have a lower burden of side effects as it w…”
BackgroundInfluentialSelf-citationDEPTOR regulates vascular endothelial cell activation and proinflammatory and angiogenic responses
Bruneau, S., Nakayama, H., Woda, C. B., Flynn, E. A., & Briscoe, D. M. (2013) · Blood · doi:10.1182/blood-2013-03-488486 · Cited by 46
A Review of metabolic staging in severely injured patients
Aller, M., Arias, J. I., Alonso-Poza, A., & Árias, J. (2010) · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · doi:10.1186/1757-7241-18-27 · Cited by 54
“lipoxins, resolvins and protectins, have been the most studied [88,89].”
BackgroundNeutrophils: Beneficial and Harmful Cells in Septic Arthritis
Boff, D., Crijns, H., Teixeira, M. M., Amaral, F. A., & Proost, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020468 · Cited by 48
“presence of neutrophils at the site of inflammation can lead to persistence of the inflammatory response, associated with complications such as tissue damage [261,262].”
BackgroundLuo, B., Wang, Z., Zhang, Z., Shen, Z., & Zhang, Z. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.005 · Cited by 42
AKT3 deficiency in M2 macrophages impairs cutaneous wound healing by disrupting tissue remodeling
Gu, S., Dai, H., Zhao, X., Gui, C., & Gui, J. (2020) · Aging · doi:10.18632/aging.103051 · Cited by 42
Marceca, G. P., Nigita, G., Calore, F., & Croce, C. M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.607196 · Cited by 57
Protein Kinase C-theta Inhibitors: A Novel Therapy for Inflammatory Disorders
Chand, S., Mehta, N., Bahia, M. S., Dixit, A., & Silakari, O. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802651625 · Cited by 46
Proresolving lipid mediators and diabetic wound healing
Hellmann, J. L., Tang, Y., & Spite, M. R. (2012) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283514e00 · Cited by 47
“Each phase of the acute inflammatory response is regulated by a multitude of positive and negative regulatory inputs that collectively orchestrate and influence whether the specific phase will proceed, how long it will proceed, and when it will terminate [14].”
BackgroundNew directions in host modulation for the management of periodontal disease
Bhatavadekar, N., & Williams, R. C. (2009) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2008.01354.x · Cited by 47
Fischer, C. D., Beatty, J. K., Duquette, S. C., Morck, D. W., Lucas, M. J., & Buret, A. G. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01598-12 · Cited by 41
“It was believed that monocyte macrophages recruited to a site of inflammation leave the inflamed tissue by lymphatic drainage following the resolution of inflammation and migrate to the lymphoid organs for antigen presentation, with only a small population of these cells undergoing apoptosis in the tissues (9, 10, 45).”
BackgroundHerrera, B. S., Coimbra, L. S., da Silva, A. R., Teixeira, S. A., Costa, S. K. P., Wallace, J. L., Spolidório, L. C., & Muscará, M. N. (2015) · Medical Gas Research · doi:10.1186/s13618-015-0025-3 · Cited by 41
“The use of NSAIDs is one of the most widely used pharmacological tools to intervene and inhibit an inflammatory response, by antagonizing pro-inflammatory pathways and/or signaling, mainly dependent on COXderived eicosanoids [41].”
BackgroundSelf-citationCytosolic PCNA interacts with p47phox and controls NADPH oxidase NOX2 activation in neutrophils
Ohayon, D., Chiara, A. D., Dang, P. M., Thiéblemont, N., Chatfield, S., Marzaioli, V., Burgener, S. S., Mocek, J., Candalh, C., Pintard, C., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20180371 · Cited by 45
“…ow nloaded from https://rupress.org/jem /article-pdf/216/11/2669/847251/jem _20180371.pdf by U niversitat Bern user on 11 February 2020 other cytosolic proteins including protein kinase C (Reeves et al., 1999) and phospholipase A2 (Shmelzer et al., 2008) and may be associated with PCNA.”
BackgroundTrojan, E., Bryniarska, N., Leśkiewicz, M., Regulska, M., Chamera, K., Szuster-Głuszczak, M., Leopoldo, M., Lacivita, E., & Basta‐Kaim, A. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191019170244 · Cited by 44
Schultz, F., Osuji, O. F., Wack, B., Anywar, G., & Garbe, L. (2021) · Plants · doi:10.3390/plants10020351 · Cited by 43
“Therefore, they are required in o der to maintain homeostasis [48,52,53].”
BackgroundEndogenous Galectin-1 and Acute Inflammation
Iqbal, A. J., Sampaio, A. L. F., Μaione, F., Greco, K. V., Niki, T., Hirashima, M., Perretti, M., & Cooper, D. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.073 · Cited by 49
Self-citationNew pathogenic insights into rheumatoid arthritis
Jutley, G. S., Raza, K., & Buckley, C. D. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000174 · Cited by 46
Self-citationNovel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammation
D’Ambrosio, R., Eastman, C. L., Fattore, C., & Perucca, E. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.54 · Cited by 43
Holmes, G. R., Anderson, S. R., Dixon, G., Robertson, A. L., Reyes-Aldasoro, C. C., Billings, S. A., Renshaw, S. A., & Kadirkamanathan, V. (2012) · Journal of The Royal Society Interface · doi:10.1098/rsif.2012.0542 · Cited by 40
Neuroprotective Effects of Annexin A1 Tripeptide after Deep Hypothermic Circulatory Arrest in Rats
Zhang, Z., Ma, Q., Shah, B., Mackensen, G. B., Lo, D. C., Mathew, J. P., Podgoreanu, M. V., & Terrando, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01050 · Cited by 48
Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes
Sima, C., Paster, B. J., & Dyke, T. E. V. (2018) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2018026750 · Cited by 45
Saving Problematic Mucosae: SPMs in Intestinal Mucosal Inflammation and Repair
Quirós, M., & Nusrat, A. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.12.004 · Cited by 47
Kain, V., Jadapalli, J. K., Tourki, B., & Halade, G. V. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104295 · Cited by 42
Aerosol inhalation of a hydrogen-rich solution restored septic renal function
Yao, W., Guo, A., Han, X., Wu, S., Chen, C., Luo, C., Li, H., Li, S., & Hei, Z. (2019) · Aging · doi:10.18632/aging.102542 · Cited by 39
“com 12098 AGING resolution is mainly characterized by neutrophil apoptosis, neutrophil elimination by macrophages, reduced secretion of pro-inflammatory cytokines and increased release of anti-inflammatory cytokines and pro-inflammatory resolution mediators [14].”
BackgroundGlucocorticoid-induced leucine zipper modulates macrophage polarization and apoptotic cell clearance
Vago, J. P., Galvão, I., Negreiros-Lima, G. L., Teixeira, L. C. R., Lima, K. M., Sugimoto, M. A., Moreira, I. Z., Jones, S. A., Lang, T., Riccardi, C., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104842 · Cited by 45
Chistyakov, D. V., Astakhova, A. A., Goriainov, S. V., & Sergeeva, M. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249577 · Cited by 44
Souza, P. R., & Norling, L. V. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.05.072 · Cited by 46
Liu, D., Mao, P., Huang, Y., Liu, Y., Liu, X., Pang, X., & Li, Y. (2014) · Mediators of Inflammation · doi:10.1155/2014/469358 · Cited by 44
Lumbroso, D., Soboh, S., Maimon, A., Schif‐Zuck, S., Ariel, A., & Burstyn‐Cohen, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.412281 · Cited by 43
Rasquel-Oliveira, F. S., da Silva, M. D. V., Martelossi-Cebinelli, G., Fattori, V., Casagrande, R., & Verri, W. A., Jr. (2023) · Molecules · doi:10.3390/molecules28135032 · Cited by 49
“Resolution is an active and highly regulated process [13].”
BackgroundCCL2 nitration is a negative regulator of chemokine-mediated inflammation
Barker, C. E., Thompson, S., O’Boyle, G., Lortat‐Jacob, H., Sheerin, N., Ali, S., & Kirby, J. A. (2017) · Scientific Reports · doi:10.1038/srep44384 · Cited by 39
de Gaetano, M., McEvoy, C. M., Andrews, D. C., Cacace, A., Hunter, J., Brennan, E. P., & Godson, C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01488 · Cited by 45
Omega‐6 and omega‐3 oxylipins as potential markers of cardiometabolic risk in young adults
Jurado‐Fasoli, L., Di, X., Köhler, I., Osuna‐Prieto, F. J., Hankemeier, T., Krekels, E. H. J., Harms, A. C., Yang, W., García-Lario, J. V., Fernández‐Veledo, S., et al. (2021) · Obesity · doi:10.1002/oby.23282 · Cited by 42
“Indeed, oxylipins influence cytokine production and release, the coagulation cascade, and leukocyte chemotaxis (38,39), supporting their role as early contributors to the low- grade systemic inflammatory status in young adults.”
BackgroundThe spinal stenosis pedometer and nutrition lifestyle intervention (SSPANLI): development and pilot
Tomkins‐Lane, C., Lafave, L. M. Z., Parnell, J. A., Rempel, J., Moriartey, S., Andreas, Y. M., Wilson, P. M., Hepler, C., Ray, H. A., & Hu, R. W. (2014) · The Spine Journal · doi:10.1016/j.spinee.2014.10.015 · Cited by 46
Stein, K., Stoffels, M., Lysson, M., Schneiker, B., Dewald, O., Krönke, G., Kalff, J. C., & Wehner, S. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3hi0515-189r · Cited by 41
“The activation of anti-inflammatory mediators provides resolution of an inflammatory response [43], and recently, lipid molecules derived from PUFA oxidation in macrophages and neutrophils have emerged as potent counter-regulators of inflammation [13].”
BackgroundChistyakov, D. V., Gavrish, G. E., Goriainov, S. V., Chistyakov, V. V., Astakhova, A. A., Azbukina, N. V., & Sergeeva, M. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051780 · Cited by 40
Goldman, A. W., Burmeister, Y., Cesnulevicius, K., Herbert, M. R., Kane, M., Lescheid, D., McCaffrey, T. A., Schultz, M., Seilheimer, B., Smit, A., et al. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00225 · Cited by 45
“It therefore seems only reasonable to target the tissue microenvironment in parallel with the stressor and the infiltrating immune cells when treating chronic inflammation (Serhan et al., 2007; Valledor et al., 2010).”
BackgroundEosinophil count predicts mortality following percutaneous coronary intervention
Toor, I. S., Jaumdally, R. J., Lip, G. Y. H., Millane, T. A., & Varma, C. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.05.033 · Cited by 38
“The immunosuppressive cytokines IL-10, IL-4, IL-13 and TGF-Beta1 are implicated in the resolution of acute inflammation and form part of the alternatively activated immune response [25–27].”
BackgroundCartwright, J. A., Lucas, C. D., & Rossi, A. G. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00055 · Cited by 41
“The responding inflammatory cells and molecular events, which preside after acute tissue damage, act to limit further injury and orchestrate efficient inflammation resolution and restoration of tissue function (Gilroy et al., 2004; Lawrence and Gilroy, 2007; Serhan et al., 2007; Poon et al., 2014).”
BackgroundSelf-citationParolini, C. (2023) · Marine Drugs · doi:10.3390/md22010017 · Cited by 41
Toll gates to periodontal host modulation and vaccine therapy
Hajishengallis, G. (2009) · Periodontology 2000 · doi:10.1111/j.1600-0757.2009.00304.x · Cited by 38
Cross-talk between CD38 and TTP Is Essential for Resolution of Inflammation during Microbial Sepsis
Joe, Y., Chen, Y., Park, J., Kim, H. J., Rah, S., Ryu, J., Cho, G. J., Choi, H., Ryter, S. W., Park, J. W., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.090 · Cited by 40
Lipoxin-mediated signaling: ALX/FPR2 interaction and beyond
Sánchez‐García, S., Jaén, R. I., Fernández‐Velasco, M., Delgado, C., Boscá, L., & Prieto, P. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106982 · Cited by 42
“Resolution of inflammation ensues from an acute response to halt the inflammatory reaction and prevent excessive tissue damage and chronic inflammation once the initial danger signal is suppressed [1,2].”
Metadata
- Authors
- Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., & Wallace, J. L.
- Affiliations
- Brigham and Women's Hospital (US)
- King's College London (GB)
- University of Birmingham (GB)
- University College London (GB)
- Centre for Inflammation Research (GB)
- Trinity College Dublin (IE)
- Queen Mary University of London (GB)
- University of Calgary (CA)
- Corresponding author
- Serhan, Charles N.
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-02
- Volume
- 21
- Issue
- 2
- Pages
- 325-332
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC3119634
- OpenAlex
- W2120699390
- Cited by
- 1,045
- References
- 36
- Citations by year
- 2026: 20 · 2025: 26 · 2024: 30 · 2023: 46 · 2022: 42 · 2021: 59 · 2020: 70 · 2019: 53 · 2018: 57 · 2017: 59 · 2016: 57 · 2015: 66 · 2014: 65 · 2013: 90 · 2012: 74
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Norges Idrettshøgskole
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- inflammation resolution, acute inflammation, anti-inflammatory agents, inflammation-associated diseases
- MeSH terms
- Animals, Anti-Inflammatory Agents, Humans, Inflammation, Leukocytes, Models, Biological, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.